These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Modelling parasite dissemination: host cell subversion and immune evasion by Toxoplasma gondii. Lambert H; Barragan A Cell Microbiol; 2010 Mar; 12(3):292-300. PubMed ID: 19995386 [TBL] [Abstract][Full Text] [Related]
47. Genome-wide comparative analysis revealed significant transcriptome changes in mice after Toxoplasma gondii infection. Jia B; Lu H; Liu Q; Yin J; Jiang N; Chen Q Parasit Vectors; 2013 Jun; 6():161. PubMed ID: 23734932 [TBL] [Abstract][Full Text] [Related]
48. Toxoplasma gondii: the model apicomplexan. Kim K; Weiss LM Int J Parasitol; 2004 Mar; 34(3):423-32. PubMed ID: 15003501 [TBL] [Abstract][Full Text] [Related]
49. A pathway to cure chronic infection with Toxoplasma gondii through immunological intervention. Suzuki Y Parasitol Int; 2021 Apr; 81():102259. PubMed ID: 33271362 [TBL] [Abstract][Full Text] [Related]
50. The known and missing links between Toxoplasma gondii and schizophrenia. Elsheikha HM; Büsselberg D; Zhu XQ Metab Brain Dis; 2016 Aug; 31(4):749-59. PubMed ID: 27041387 [TBL] [Abstract][Full Text] [Related]
51. The tyrosine transporter of Toxoplasma gondii is a member of the newly defined apicomplexan amino acid transporter (ApiAT) family. Parker KER; Fairweather SJ; Rajendran E; Blume M; McConville MJ; Bröer S; Kirk K; van Dooren GG PLoS Pathog; 2019 Feb; 15(2):e1007577. PubMed ID: 30742695 [TBL] [Abstract][Full Text] [Related]
52. Use and abuse of dendritic cells by Toxoplasma gondii. Sanecka A; Frickel EM Virulence; 2012 Nov; 3(7):678-89. PubMed ID: 23221473 [TBL] [Abstract][Full Text] [Related]
53. Self-mating in the definitive host potentiates clonal outbreaks of the apicomplexan parasites Sarcocystis neurona and Toxoplasma gondii. Wendte JM; Miller MA; Lambourn DM; Magargal SL; Jessup DA; Grigg ME PLoS Genet; 2010 Dec; 6(12):e1001261. PubMed ID: 21203443 [TBL] [Abstract][Full Text] [Related]
54. Anti-Toxoplasma host defense systems and the parasitic counterdefense mechanisms. Sasai M; Yamamoto M Parasitol Int; 2022 Aug; 89():102593. PubMed ID: 35500831 [TBL] [Abstract][Full Text] [Related]
55. Comprehensive Characterization of Fu Y; Cui X; Fan S; Liu J; Zhang X; Wu Y; Liu Q mBio; 2018 Oct; 9(5):. PubMed ID: 30352931 [TBL] [Abstract][Full Text] [Related]
56. The Neurotropic Parasite Toxoplasma gondii Induces Sustained Neuroinflammation with Microvascular Dysfunction in Infected Mice. Estato V; Stipursky J; Gomes F; Mergener TC; Frazão-Teixeira E; Allodi S; Tibiriçá E; Barbosa HS; Adesse D Am J Pathol; 2018 Nov; 188(11):2674-2687. PubMed ID: 30121257 [TBL] [Abstract][Full Text] [Related]
57. Neurons are the Primary Target Cell for the Brain-Tropic Intracellular Parasite Toxoplasma gondii. Cabral CM; Tuladhar S; Dietrich HK; Nguyen E; MacDonald WR; Trivedi T; Devineni A; Koshy AA PLoS Pathog; 2016 Feb; 12(2):e1005447. PubMed ID: 26895155 [TBL] [Abstract][Full Text] [Related]
59. Blocking Palmitoylation of Toxoplasma gondii Myosin Light Chain 1 Disrupts Glideosome Composition but Has Little Impact on Parasite Motility. Rompikuntal PK; Kent RS; Foe IT; Deng B; Bogyo M; Ward GE mSphere; 2021 May; 6(3):. PubMed ID: 34011689 [No Abstract] [Full Text] [Related]
60. α2-3 Sialic acid glycoconjugate loss and its effect on infection with Toxoplasma parasites. Nishikawa Y; Ogiso A; Kameyama K; Nishimura M; Xuan X; Ikehara Y Exp Parasitol; 2013 Nov; 135(3):479-85. PubMed ID: 23988663 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]